We understand that every startup has to follow its own journey. Each individual odyssey can transform a good idea into a global success and an initial business plan into a household name. The decisions made, connections forged, and milestones reached along the way are how young startups earn their place as leaders on the international stage and how some of them can transform our future for the better.
We target companies for investment just as they are beginning to scale their business and operations. Headquartered in Tel Aviv and Boston and with years of experience in North America, Europe and Asia, we are excited to serve as a springboard for Israeli companies expanding globally.
As former business executives, we seek to partner with exceptional entrepreneurs and to support their efforts to build global enterprises. We are here to help, providing advice and leveraging our global network as you chart your path in the realms of business strategy, customer success, technology development and finance.
New Era is the first of its kind ESG technology investment fund with an “Israeli nexus” focus.
Our work with leadership teams is based on mutual respect, a shared excitement about building great companies and an appreciation for the importance of creating a culture of success anchored by positive societal values.
Gideon is also an Advisory Director of Berkshire Partners, an investment firm based in Boston. From 2004 to 2012 he was President and CEO of Entegris, a global supplier of products used in the production of high technology components and substrates. From 2001 to 2004 he was a Managing Director of Parthenon Capital, a private equity partnership based in Boston. From 1991 to 2000 he was Chairman, President and CEO of Kollmorgen Corporation, a supplier of high-performance electronic motion control products. Gideon is a serial angel investor in Israeli technology companies and served as the chairman of Fundtech and Servotronix.
Gideon is the founder of the Shlomo Argov Fellows program for leadership in the public sector at Reichman University (IDC Herzliya) in Israel and a trustee of the Beth Israel Deaconess Medical Center in Boston. He received his BA from Harvard University (Economics, magna cum laude) and his MBA from the Stanford Graduate School of Business.
Ran served as Economic & Technology Advisor at the Office of the President during the presidency of Shimon Peres, becoming one of his most senior advisors, and leading numerous technological and scientific projects to promote the State of Israel on the world arena. Following the completion of the presidency of Shimon Peres, Ran assumed an integral role in the establishment of Peres and Associates advisory firm. Ran’s finance career began at Lehman Brothers and was followed by an Investment Manager position at Portland Capital Hedge Fund. He received his BA in Electrical Engineering & Computer Science from UCL in the UK and his MBA from the Kellogg School of Management at Northwestern University in the US. In addition, he completed the investment management program at London Business School and an executive program at Harvard Business School. During his career, Ran has advised on numerous transactions in a range of fields. Ran also serves as co chairman of the innovation expo at the Israeli Innovation Center.
Ziv was an Associate Partner at McKinsey & Company, where he led large Digital, Technology, and Advance Analytics transformations across various industries. At McKinsey, Ziv also advised on Digitally focused transactions for Fortune 500 companies, designed the strategy for fast growth companies, and led digital business building efforts for incumbents. Ziv’s career started in the Israeli Intelligence Corps, where he led technological, intelligence, and operational teams in Unit 8200 (the Signal Intelligence Unit). Ziv finished his service as a Major. Ziv received his Masters of Business Administration from MIT and his B.Sc in Computer Science from the Open University of Israel (during his military service).
Ayelet is one of Israel’s leading strategic and business development advisors and an expert in PR, communications, branding and media with over twenty years of experience in the field. Ayelet worked very closely with President Shimon Peres, both during and after his presidency, in which she served as the President’s senior business development and PR advisor, as well as managed all of his strategic branding, media and communications.
The connections and experience she acquired while working with President Peres bring added value to New Era, as she connects New Era's portfolio companies with top-tier international firms, entrepreneurs and businesspeople around the globe. Ayelet has a proven record of delivering top results and has executed world-class international and national campaigns and projects in which she utilizes her broad network of international contacts. Ayelet holds a BA in Communications and Management and MA in Journalism, both of which she was awarded from the Hebrew University of Jerusalem.
Danny is an Israeli CPA and worked at Deloitte from 1990 to 1996.
Following that, he served as CFO of Ranex buying services LTD until 2018.
Danny holds a bachelor's degree in accounting and finance
from the College of Management Academic Studies in Tel Aviv. He has a CPA license from 1992.
Shira joined New Era Capital Partners in December 2016.
Prior to New Era, Shira worked at Peres and Associates Global Advisory
as office manager.
Shira holds a B.Ed. F.A., a joint bachelor’s degree in education and arts from The Faculty of Arts - Hamidrasha at Beit Berl College.
Eugenio spent 4 years in the US, where he graduated from Brandeis University with a BA in Economics and Business cum laude in 2017. Recently, Eugenio completed an MBA with focus on Innovation and Entrepreneurship at Reichman University (IDC Herzliya). Before joining New Era Eugenio worked at LVenture Group in Rome.
Chairman of the Board of Directors of the Peres Center for Peace & Innovation
Co-Founder and Managing General Partner of Pitango Venture Capital, Israel's largest venture capital fund, which invests in a wide range of technological fields, from information technology to medical technologies.
Member of the Board of Directors of Teva Pharmaceutical Industries Ltd.
Co-founder and former Chairman of the Israel Venture Association
Professor of Medicine and Engineering.
Founding Director and CEO, Lawrence J. Ellison Institute for Transformative Medicine of USC.
Co-founder of Two pioneering personalized medicine companies - Navigenics and Applied Proteomics.
Cum Laude Molecular Biology - Princeton University.
MD - University of Pennsylvania School of Medicine.
Berkshire Partners - Co-founder and Managing Director for over 30 years.
Serves on the Finance Committee of the Harvard Corporation, the Governing
Board of Harvard University.
University of Haifa - Chairman of the Board of Governors.
B.A. in economics from Harvard College and M.B.A. from Harvard Business School as a Baker Scholar.
Founder & CEO of Servotronix Motion Control Ltd and Servotronix Motion System Ltd.
Board member of Servotronix, LEM (SIX: LEHN), EZ-Reider, Caja Systems.
President of Negba; association for children at risk.
Ph.D. in Control System Engineering from Polytechnique - Université Libre De Bruxelles Belgium.
Expert on management and corporate strategy.
Received multiple awards for distinguished leadership, both in the US and abroad.
Advises international top level management in various cooperation fields.
BA, Summa Cum Laude from Hebrew University, Jerusalem.
MBA with highest honors from Harvard Business School.
Flex- Senior Vice President Finance Global Operation and Components.
Member of the Board of BlueBank Technologies, China.
Over 15 years of international top- level experience.
BA Accounting from The College of Management Academic Studies.
Advanced coursework and executive graduate programs from Stanford University.
Board of Directors – Amelia Investments.
Founder/Manager Claridge Israel.
CEO Koor Industries.
BA Near Easten Language and Literature from Harvard University.
Director Peres Center for Peace.
Chairman Friends of the Tel Aviv Medical Center.
23 years with J.P Morgan’s Wealth Management business.
Head of J.P. Morgan's Investment Solutions business.
Head of Global Investments practice.
Graduate of the University of Virginia.
Serves on numerous boards.
After a successful due diligence process the investment committee will convene for a final decision. The committee will take into account the recommendation of the investment team as well as assess whether New Era can assist and add value as the potential company grows and expand.
This is your opportunity to show us in more detail why you believe in your solution.
We will ask for access to your data room, or any off-the-shelf materials you can share. Our typical DD process spans across:
We may also conduct calls with external experts, as well as with existing customers, prospective customers, and other stakeholders (e.g., existing Board members)
The full process can range between 1-4 weeks, depending on follow-up questions and the status of the round.
We want to first take time to know you and your story, and introduce ourselves. The most successful partnerships we had started with a strong relationship from the first call.
At a high level, in a 1-hour call, we typically expect to get to know the team and understand the problem definition, solution, product & technology, market, GTM strategy, current status, and expected deal economics.
After a successful due diligence process the investment committee will convene for a final decision. The committee will take into account the recommendation of the investment team as well as assess whether New Era can assist and add value as the potential company grows and expand.
This is your opportunity to show us in more detail why you believe in your solution.
We will ask for access to your data room, or any off-the-shelf materials you can share. Our typical DD process spans across:
We may also conduct calls with external experts, as well as with existing customers, prospective customers, and other stakeholders (e.g., existing Board members)
The full process can range between 1-4 weeks, depending on follow-up questions and the status of the round.
We want to first take time to know you and your story, and introduce ourselves.
The most successful partnerships we had started with a strong relationship from the first call.
At a high level, in a 1-hour call, we typically expect to get to know the team and understand
the problem definition, solution, product & technology, market, GTM strategy, current status, and expected deal economics.
